Identifying the potential for tamoxifen resistance in patients
Thursday, June 11, 2009 - 07:57
in Health & Medicine
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumour cells are a major cause of death. In a study in this month's Molecular and Cellular Proteomics, researchers have uncovered a protein profile that may accurately predict whether a cancer will be tamoxifen resistant...
Read the whole article on Science Centric
More from Science Centric
Related
- Identifying the potential for tamoxifen resistance in patientsWed, 10 Jun 2009, 16:43:34 EDT
- 'New' estrogen receptor found to be key player in tamoxifen resistanceThu, 30 Oct 2008, 6:57:00 EDT
- Novel basis identified for tamoxifen failureThu, 4 Dec 2008, 4:37:28 EST
- Cholesterol appears to promote tamoxifen resistance in some breast cancer cells say GUMC researchersMon, 20 Apr 2009, 17:09:04 EDT
- A new take on growth factor signaling in tamoxifen resistanceTue, 23 Jun 2009, 19:38:33 EDT